Industry’s Lesson On Non-Inferiority Margins In Anti-Infective Trials: Use 10%
• By Lauren Smith
If industry is to learn anything from the three-day Anti-Infective Drugs Advisory Committee meeting on how to correctly use non-inferiority margins in trials, it is to adhere to the panel's recommendation of 10 percent (at least for now)
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
